AI Science Tracker
EN

Diagnostic performance of artificial intelligence to identify deeply invasive colorectal cancer on non-magnified plain endoscopic images

University of Tokyo; National Cancer Center Hospital East · 22 Sep 2020 · medicine

Discovery

Diagnostic performance of artificial intelligence to identify deeply invasive colorectal cancer on non-magnified plain endoscopic images

Source check: Source checked. Not independent scientific confirmation.

Finding: A fine-tuned ResNet-50 computer-aided diagnosis system classified deeply invasive T1b colorectal cancer from non-magnified endoscopic images. In a third-hospital test set of 44 lesions, it outperformed novice readers on specificity but was slightly below expert readers. The authors did not test real-time colonoscopy.

Technology: A pretrained ResNet-50 CNN is fine-tuned to estimate the probability that an endoscopic image depicts deeply invasive T1b colorectal cancer.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
A pretrained ResNet-50 CNN is fine-tuned to estimate the probability that an endoscopic image depicts deeply invasive T1b colorectal cancer.
Test and result
Third-hospital lesion-level evaluation reported AUC 0.888; at the study threshold, specificity was 87%, sensitivity 81% and accuracy 84%. The cohort contained 44 lesions.
Limitation / still unknown
Small retrospective test set; performance was below experts and no real-time or clinical-outcome evaluation was performed.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC7508661/ · https://pubmed.ncbi.nlm.nih.gov/33015336/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary source full text, including Methods and Results; first result-bearing version checked against primary publication metadata..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.